4

PRIMARY DOCUMENT

Company: ENDONOVO THERAPEUTICS, INC.
Filed: October 3, 2019
Period of Report: September 30, 2019
Accession Number: 0001645470-19-000051

View Document ↗ View on SEC.gov ↗